These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 20045673

  • 1. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H, Kondo Y, Nakahata S, Hamasaki M, Sakoda S, Morishita K.
    Biochem Biophys Res Commun; 2010 Jan 22; 391(4):1785-91. PubMed ID: 20045673
    [Abstract] [Full Text] [Related]

  • 2. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.
    Liu N, Wang L, Liu X, Yang Q, Zhang J, Zhang W, Wu Y, Shen L, Zhang Y, Yang A, Han H, Zhang J, Yao L.
    Biochem Biophys Res Commun; 2007 Jun 22; 358(1):164-9. PubMed ID: 17470364
    [Abstract] [Full Text] [Related]

  • 3. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma.
    Uesugi H, Uzawa K, Kawasaki K, Shimada K, Moriya T, Tada A, Shiiba M, Tanzawa H.
    Int J Mol Med; 2005 Apr 22; 15(4):597-602. PubMed ID: 15754020
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma.
    Imai MA, Moriya T, Imai FL, Shiiba M, Bukawa H, Yokoe H, Uzawa K, Tanzawa H.
    Int J Mol Med; 2005 Apr 22; 15(4):585-9. PubMed ID: 15754018
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
    Feng L, Xie Y, Zhang H, Wu Y.
    Biochem Biophys Res Commun; 2011 Mar 25; 406(4):534-8. PubMed ID: 21352815
    [Abstract] [Full Text] [Related]

  • 6. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
    Lee DC, Kang YK, Kim WH, Jang YJ, Kim DJ, Park IY, Sohn BH, Sohn HA, Lee HG, Lim JS, Kim JW, Song EY, Kim DM, Lee MN, Oh GT, Kim SJ, Park KC, Yoo HS, Choi JY, Yeom YI.
    Cancer Res; 2008 Jun 01; 68(11):4210-20. PubMed ID: 18519680
    [Abstract] [Full Text] [Related]

  • 7. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H, Zhang J, Lu J, He X, Chen C, Li X, Gong L, Bao G, Fu Q, Chen S, Lin W, Shi H, Ma J, Liu X, Ma Q, Yao L.
    BMC Cancer; 2008 Oct 22; 8():303. PubMed ID: 18940011
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J, Kim JH, Paeng JY, Kim MJ, Hong SD, Lee JI, Hong SP.
    J Clin Pathol; 2005 Nov 22; 58(11):1199-205. PubMed ID: 16254112
    [Abstract] [Full Text] [Related]

  • 9. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
    Liu NG, Shan CM, Wu SH, Lu ZH, Kang GY.
    Ai Zheng; 2004 Jun 22; 23(6):635-9. PubMed ID: 15191661
    [Abstract] [Full Text] [Related]

  • 10. [Expression of candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colon cancer].
    Chu DK, Zhang J, Shi H, Dong GL, Liu XP, Wang WZ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul 22; 11(4):354-7. PubMed ID: 18636358
    [Abstract] [Full Text] [Related]

  • 11. Biological and prognostic significance of NDRG2 downregulation in oral squamous cell carcinoma.
    Ahn CH, Kim JH, Shim HW, Shin WJ, Cho YA, Yoon HJ.
    Oral Dis; 2024 Oct 22; 30(7):4287-4302. PubMed ID: 38887830
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation.
    Wu HT, Ko SY, Fong JH, Chang KW, Liu TY, Kao SY.
    J Oral Pathol Med; 2009 Feb 22; 38(2):206-13. PubMed ID: 18331557
    [Abstract] [Full Text] [Related]

  • 15. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
    Zhang L, Yang X, Zhong LP, Zhou XJ, Pan HY, Wei KJ, Li J, Chen WT, Zhang ZY.
    J Oral Pathol Med; 2009 Apr 22; 38(4):362-70. PubMed ID: 18673418
    [Abstract] [Full Text] [Related]

  • 16. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
    Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J.
    Cancer Res; 2011 Sep 01; 71(17):5765-78. PubMed ID: 21795477
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
    Kato H, Uzawa K, Onda T, Kato Y, Saito K, Nakashima D, Ogawara K, Bukawa H, Yokoe H, Tanzawa H.
    Int J Oncol; 2006 Apr 01; 28(4):873-81. PubMed ID: 16525636
    [Abstract] [Full Text] [Related]

  • 18. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
    Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J.
    Cancer Res; 2008 Apr 01; 68(7):2094-105. PubMed ID: 18381414
    [Abstract] [Full Text] [Related]

  • 19. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
    Liu HW, Hu BQ, Cao CF.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar 01; 40(2):94-7. PubMed ID: 15842853
    [Abstract] [Full Text] [Related]

  • 20. Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential.
    Tamura T, Ichikawa T, Nakahata S, Kondo Y, Tagawa Y, Yamamoto K, Nagai K, Baba T, Yamaguchi R, Futakuchi M, Yamashita Y, Morishita K.
    Cancer Res; 2017 May 01; 77(9):2363-2374. PubMed ID: 28209617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.